Acupuncture needles aim to stop Chemo's nerve pain

NCT ID NCT07663396

Not yet recruiting Prevention Sponsor: Affiliated Hospital of Qinghai University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether electroacupuncture (using mild electric pulses on needles) plus tiny thumbtack needles can prevent nerve damage caused by chemotherapy in people with early-stage cancer. About 278 patients with breast, stomach, bowel, lung, or ovarian cancer will receive the treatment during chemo. The goal is to see if this approach reduces the chance of developing painful nerve problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: electroacupuncture and thumbtack needles
What this could lead to: If it works, this could offer a drug-free way to prevent painful nerve damage from chemotherapy, improving quality of life for cancer patients.
What could go wrong: This is an early-stage trial with no results yet. The effect may be small or not work for everyone, and the needles may cause minor discomfort or bruising.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer gastric cancer intestinal cancer microinvasive gastric cancer non-small cell lung carcinoma ovarian cancer peripheral nervous system disorder peripheral neuropathy chemotherapy-induced neuropathy prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHEMOTHERAPY EARLY STAGE CANCER ELECTROACUPUNCTURE PERIPHERAL NEUROPATHY

Contacts and locations

Locations

Qinghai University Affiliated Hospital

Xining, Qinghai, 810000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.